Hematopoietic stem cells are the stem cells of the blood that are applied to treat hematological disorders by transplanting donor cells to a patient. Rarity of donors and low cell counts in alternative hematopoietic stem cell sources such as cord blood limit the clinical use of hematopoietic stem cells. Here, it is shown that bifunctional surfaces containing the adhesive RGD peptide together with the Notch‐activating Delta‐like 1 (DLL1)—provided in a nanopatterned or unpatterned manner in different densities—are able to enhance hematopoietic stem and progenitor cell proliferation. Nanopatterning allows determining the maximal distance between DLL1 molecules that results in efficient cell stimulation (40 nm). Applying unpatterned substrates with statistically distributed DLL1 shows that the elicited effects depend on ligand density and clustering (minimum 2 molecules/cluster). Thereby, the present study contributes to the development of cost‐efficient bioreactors for hematopoietic stem cell expansion and to deciphering how cells gain control over Notch signaling by DLL1 clustering.
No takes yet. Share an insight, caveat, or question.
Winkler et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: